News
The Indian pharmaceutical market (IPM) grew by 8.4 per cent in the financial year (FY) 2025 on the back of major therapies ...
Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...
Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...
Established under President Joe Biden’s Inflation Reduction Act of 2022, the Medicare Drug Price Negotiation Program allows ...
It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.
Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...
Ozempic has already taken the world by storm as a weight loss game-changer, but now, scientists say its impact might go much deeper than the number on the scale. New research suggests that this widely ...
Ozempic may be known for weight loss, but new studies reveal it could also protect brain health and lower your risk of dementia and Alzheimer’s.
Dapagliflozin is indicated for both type 2 diabetes and heart failure ... and slow the progression toward end-stage kidney disease Empagliflozin can be used to help achieve the following in ...
AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results